Table 2.

Effects of TT supplementation on serum fatty acid metabolites in mice fed HFD compared to the HFD control group.

Sub Pathway	Metabolite Name	HFD+TT800/HFD
Fatty acid branched	13-methylmyristate	0.80
Medium chain fatty acid	heptanoate (C7:0)	1.13
	pelargonate (C9:0)	0.84
	10-undecenoate (C11:1n1)	0.69
Fatty acid monohydroxy	2-hydroxyoctanoate	0.84
	9-HODE + 13-HODE	0.71
	14-HDoHE/17-HDoHE	0.82
Fatty acid, dicarboxylate	2-hydroxyadipate	0.69
	suberate (octanedioate)	0.81
	azelate (nonanedioate)	0.79
	sebacate (decanedioate)	0.77
	Undecanedioate	0.81
	1,11-undecanedicarboxylate	0.75
	dodecanedioate	0.81
	tetradecanedioate	0.80
	hexadecanedioate	0.85
	Octadecanedioate	0.79
Eicosanoid	Thromboxane B2	0.45
	12-HHTE	0.72
	12-HHTrE	0.47
Endocannabinoid	oleoyl ethanolamide	1.07
	palmitoyl ethanolamide	1.09
	linoleoyl ethanolamide	1.11
Fatty acid acyl glycine	Valerylglycine	0.61
	Hexanoylglycine	0.51
	heptanoyl glycine	0.53
	3,4-methylene heptanoylglycine	0.63
	N-octanoylglycine	0.57
	N-palmitoylglycine	0.93
Fatty acid acyl carnitine	hexanoylcarnitine (C6)	0.71
	decanoylcarnitine (C10)	1.29
	lignoceroylcarnitine (C24)	1.18
Carnitine	Carnitine	1.22

Metabolite values are expressed as the ratio of HFD+TT800/HFD which is the fold change of the treated HFD+TT800 group compared to the HFD control group. A ratio greater than 1 indicates a value larger for the treated group (HFD+TT800) and less than 1 the value for HFD+TT800 group is lower compared to the HFD control group. Green indicates fold reduction and red is for fold increase by TT supplementation with p ≤ 0.05 obtained from the Student’s t-test. Yellow indicates fold reduction and pink is for fold increase by TT supplementation with 0.05 < p < 0.1 that was obtained from the Student’s t-test.